title: Generation of human CEACAM1 transgenic mice and binding of Neisseria Opa protein to their neutrophils.
abstract: BACKGROUND
  Human CEACAM1 is a cell-cell adhesion molecule with multiple functions including insulin clearance in the liver, vasculogenesis in endothelial cells, lumen formation in the mammary gland, and binding of certain human pathogens.
  
  
  RESULTS
  Three genomic BAC clones containing the human CEACAM1 gene were microinjected into pronuclei of fertilized FVB mouse oocytes. The embryos were implanted in the oviducts of pseudopregnant females and allowed to develop to term. DNA from newborn mice was evaluated by PCR for the presence of the human CEACAM1 gene. Feces of the PCR positive offspring screened for expression of human CEACAM1. Using this assay, one out of five PCR positive lines was positive for human CEACAM1 expression and showed stable transmission to the F1 generation with the expected transmission frequency (0.5) for heterozygotes. Liver, lung, intestine, kidney, mammary gland, and prostate were strongly positive for the dual expression of both murine and human CEACAM1 and mimic that seen in human tissue. Peripheral blood and bone marrow granulocytes stained strongly for human CEACAM1 and bound Neisseria Opa proteins similar to that in human neutrophils.
  
  
  CONCLUSIONS
  These transgenic animals may serve as a model for the binding of human pathogens to human CEACAM1.
authors.affiliation: Department of Immunology, Beckman Research Institute of the City of Hope, Duarte, California, United States of America.
authors.forename: Angel
authors.initials: A
authors.lastname: Gu
authors.forename: Zhifang
authors.initials: Z
authors.lastname: Zhang
authors.forename: Nan
authors.initials: N
authors.lastname: Zhang
authors.forename: Walter
authors.initials: W
authors.lastname: Tsark
authors.forename: John E
authors.initials: JE
authors.lastname: Shively
mesh_terms: D000818:Animals; D015703:Antigens, CD / Q000032:analysis / Q000235:genetics*; D001426:Bacterial Proteins / Q000378:metabolism*; D002272:Carcinoembryonic Antigen / Q000032:analysis; D015815:Cell Adhesion Molecules / Q000032:analysis / Q000235:genetics*; D004195:Disease Models, Animal; D006801:Humans; D051379:Mice; D008822:Mice, Transgenic; D009343:Neisseria; D009504:Neutrophils / Q000378:metabolism* / Q000382:microbiology; D011485:Protein Binding; D014018:Tissue Distribution
chemical_list: D015703:Antigens, CD; D001426:Bacterial Proteins; C069847:CD66 antigens; D002272:Carcinoembryonic Antigen; C486183:Ceacam1 protein, mouse; D015815:Cell Adhesion Molecules
references.citation: Mol Biol Cell. 2000 Jan;11(1):65-77
references.pmid: 10637291
references.citation: J Biol Chem. 2001 Dec 14;276(50):47421-33
references.pmid: 11595750
references.citation: J Leukoc Biol. 2003 Jul;74(1):126-34
references.pmid: 12832451
references.citation: Mol Microbiol. 1996 Dec;22(5):941-50
references.pmid: 8971715
references.citation: Infect Immun. 2005 Jul;73(7):4171-9
references.pmid: 15972507
references.citation: Oncogene. 1999 Sep 30;18(40):5563-72
references.pmid: 10523833
references.citation: Nucleic Acids Res. 1993 Oct 11;21(20):4783-7
references.pmid: 8233827
references.citation: J Clin Invest. 2004 Oct;114(7):944-52
references.pmid: 15467833
references.citation: Ann N Y Acad Sci. 2006 Aug;1072:155-75
references.pmid: 17057197
references.citation: Nat Immunol. 2002 Mar;3(3):229-36
references.pmid: 11850628
references.citation: Mol Microbiol. 1999 Nov;34(3):538-51
references.pmid: 10564495
references.citation: Adv Exp Med Biol. 1998;440:569-74
references.pmid: 9782331
references.citation: Mucosal Immunol. 2008 Nov;1 Suppl 1:S39-42
references.pmid: 19079227
references.citation: Mol Cell Endocrinol. 2001 Nov 26;184(1-2):115-23
references.pmid: 11694347
references.citation: J Leukoc Biol. 1996 Jul;60(1):106-17
references.pmid: 8699114
references.citation: Proc Natl Acad Sci U S A. 2003 Jan 21;100(2):521-6
references.pmid: 12522268
references.citation: Immunity. 2006 Nov;25(5):769-81
references.pmid: 17081782
references.citation: Mol Cell. 2000 Feb;5(2):311-20
references.pmid: 10882072
references.citation: Dev Dyn. 1996 Jul;206(3):272-90
references.pmid: 8896983
references.citation: J Leukoc Biol. 2008 Sep;84(3):780-8
references.pmid: 18524973
references.citation: J Clin Invest. 2006 Jun;116(6):1596-605
references.pmid: 16680193
references.citation: Exp Biol Med (Maywood). 2008 Jul;233(7):849-59
references.pmid: 18445773
references.citation: Biochem J. 2001 Apr 15;355(Pt 2):417-23
references.pmid: 11284729
references.citation: Mol Cancer. 2008 May 28;7:46
references.pmid: 18507857
references.citation: Nat Genet. 2002 Mar;30(3):270-6
references.pmid: 11850617
references.citation: Nat Rev Immunol. 2006 Jun;6(6):433-46
references.pmid: 16724098
references.citation: Oncogene. 2007 Dec 6;26(55):7637-46
references.pmid: 17546042
references.citation: J Cell Sci. 1999 Dec;112 ( Pt 23):4193-205
references.pmid: 10564638
references.citation: J Biol Chem. 1999 Jan 1;274(1):335-44
references.pmid: 9867848
references.citation: J Immunol. 2004 Mar 15;172(6):3535-43
references.pmid: 15004154
references.citation: Trends Endocrinol Metab. 2002 Aug;13(6):240-5
references.pmid: 12128284
references.citation: Eur J Biochem. 1999 Sep;264(2):534-44
references.pmid: 10491101
references.citation: Genomics. 1991 Jul;10(3):583-7
references.pmid: 1653760
references.citation: Cell Microbiol. 2007 Feb;9(2):329-46
references.pmid: 16953805
references.citation: Nat Immunol. 2008 Nov;9(11):1270-8
references.pmid: 18836450
references.citation: J Cell Sci. 2005 Dec 1;118(Pt 23):5513-24
references.pmid: 16291724
references.citation: EMBO J. 1998 Jan 15;17(2):443-54
references.pmid: 9430636
references.citation: Cancer Res. 2004 May 1;64(9):3072-8
references.pmid: 15126343
references.citation: EMBO J. 1997 Jun 16;16(12):3435-45
references.pmid: 9218786
references.citation: Eur J Immunol. 1994 Jun;24(6):1383-90
references.pmid: 8206098
references.citation: Clin Exp Immunol. 1979 Jun;36(3):436-41
references.pmid: 385181
references.citation: J Biol Chem. 2007 Feb 23;282(8):5749-60
references.pmid: 17192268
references.citation: J Leukoc Biol. 2009 Aug;86(2):205-18
references.pmid: 19454653
references.citation: Cancer Res. 1998 Apr 1;58(7):1469-77
references.pmid: 9537250
references.citation: Oncogene. 1997 Feb 20;14(7):783-90
references.pmid: 9047385
references.citation: Int J Cancer. 1990 May 15;45(5):875-8
references.pmid: 2335390
references.citation: J Immunol. 2008 May 1;180(9):6085-93
references.pmid: 18424730
references.citation: Exp Cell Res. 2009 Apr 15;315(7):1225-33
references.pmid: 19146852
references.citation: Eur J Immunol. 2005 Jun;35(6):1949-59
references.pmid: 15909305
references.citation: J Immunol. 1983 May;130(5):2308-15
references.pmid: 6187849
references.citation: Lung Cancer. 2008 Jun;60(3):309-12
references.pmid: 18462829